back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-10-28 10:40 Tx date 2019-10-28 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+5,000 vol $0.54 each |
473,220 | |
| Filed 2019-10-16 12:38 Tx date 2019-10-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
468,220 | |
| Filed 2019-10-03 16:03 Tx date 2019-10-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$780.00
+1,500 vol $0.52 each |
463,220 | |
| Filed 2019-10-03 16:03 Tx date 2019-10-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,785
+3,500 vol $0.51 each |
461,720 | |
| Filed 2019-09-20 03:36 Tx date 2019-09-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+5,000 vol $0.60 each |
458,220 | |
| Filed 2018-10-27 Tx date 2018-10-24 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,050
-5,000 vol $0.81 each |
453,220 | |
| Filed 2018-10-23 Tx date 2018-10-22 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,350
-5,000 vol $0.87 each |
463,220 | |
| Filed 2018-10-23 Tx date 2018-10-19 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,300
-5,000 vol $0.86 each |
468,220 | |
| Filed 2018-10-23 Tx date 2018-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,250
-5,000 vol $0.85 each |
458,220 | |
| Filed 2018-10-10 Tx date 2018-10-05 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,100
-5,000 vol $0.82 each |
478,220 | |
| Filed 2018-10-10 Tx date 2018-10-09 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,550
-5,000 vol $0.91 each |
473,220 | |
| Filed 2018-10-05 Tx date 2018-10-01 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,600
-5,000 vol $0.92 each |
488,220 | |
| Filed 2018-10-05 Tx date 2018-10-04 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,150
-5,000 vol $0.83 each |
483,220 | |
| Filed 2018-07-12 Tx date 2018-07-12 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,650
-5,000 vol $1.13 each |
493,220 | |
| Filed 2018-07-12 Tx date 2018-07-11 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,250
-5,000 vol $1.05 each |
498,220 | |
| Filed 2018-07-12 Tx date 2018-07-11 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,100
-5,000 vol $1.02 each |
503,220 | |
| Filed 2018-07-12 Tx date 2018-07-10 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,265
-5,000 vol $1.05 each |
508,220 | |
| Filed 2018-07-12 Tx date 2018-07-09 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,550
-5,000 vol $1.11 each |
513,220 | |
| Filed 2018-07-07 Tx date 2018-07-06 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,500
-5,000 vol $1.10 each |
518,220 | |
| Filed 2018-07-07 Tx date 2018-07-05 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,650
-5,000 vol $1.13 each |
523,220 | |
| Filed 2018-07-07 Tx date 2018-07-05 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,750
-5,000 vol $1.15 each |
528,220 | |
| Filed 2018-07-07 Tx date 2018-07-03 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,750
-5,000 vol $1.15 each |
538,220 | |
| Filed 2018-07-07 Tx date 2018-07-04 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,700
-5,000 vol $1.14 each |
533,220 | |
| Filed 2018-06-29 Tx date 2018-06-26 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,400
-5,000 vol $1.08 each |
563,220 | |
| Filed 2018-06-29 Tx date 2018-06-27 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-560.00
-500 vol $1.12 each |
558,220 | |
| Filed 2018-06-29 Tx date 2018-06-27 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,100
-5,000 vol $1.22 each |
553,220 | |
| Filed 2018-06-29 Tx date 2018-06-29 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,600
-10,000 vol $1.16 each |
543,220 | |
| Filed 2018-06-29 Tx date 2018-06-25 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,800
-2,500 vol $1.12 each |
570,720 | |
| Filed 2018-06-29 Tx date 2018-06-25 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,775
-2,500 vol $1.11 each |
568,220 | |
| Filed 2018-06-29 Tx date 2018-06-27 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,995
-4,500 vol $1.11 each |
558,720 | |
| Filed 2018-06-23 Tx date 2018-06-22 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,550
-5,000 vol $1.11 each |
573,220 | |
| Filed 2018-06-23 Tx date 2018-06-19 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,800
-5,000 vol $1.16 each |
593,220 | |
| Filed 2018-06-23 Tx date 2018-06-19 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,640
-4,000 vol $1.16 each |
589,220 | |
| Filed 2018-06-23 Tx date 2018-06-19 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,150
-1,000 vol $1.15 each |
588,220 | |
| Filed 2018-06-23 Tx date 2018-06-20 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,750
-5,000 vol $1.15 each |
583,220 | |
| Filed 2018-06-23 Tx date 2018-06-21 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,550
-5,000 vol $1.11 each |
578,220 | |
| Filed 2018-06-16 Tx date 2018-06-15 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,950
-5,000 vol $1.19 each |
598,220 | |
| Filed 2018-06-16 Tx date 2018-06-15 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,950
-5,000 vol $1.19 each |
603,220 | |
| Filed 2018-06-16 Tx date 2018-06-14 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-5,000 vol $1.20 each |
608,220 | |
| Filed 2018-06-16 Tx date 2018-06-13 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,350
-5,000 vol $1.27 each |
613,220 | |
| Filed 2018-06-16 Tx date 2018-06-12 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,400
-5,000 vol $1.28 each |
618,220 | |
| Filed 2018-06-16 Tx date 2018-06-12 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,350
-5,000 vol $1.27 each |
623,220 | |
| Filed 2018-06-10 Tx date 2018-06-08 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,150
-5,000 vol $1.23 each |
628,220 | |
| Filed 2018-06-10 Tx date 2018-06-07 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,700
-5,000 vol $1.14 each |
633,220 | |
| Filed 2018-04-05 Tx date 2018-04-04 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-5,000 vol $0.60 each |
638,220 | |
| Filed 2018-04-03 Tx date 2018-04-03 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,800
-10,000 vol $0.58 each |
643,220 | |
| Filed 2018-03-27 Tx date 2018-03-27 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,750
-5,000 vol $0.55 each |
653,220 | |
| Filed 2018-03-26 Tx date 2018-03-26 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,750
-5,000 vol $0.55 each |
658,220 | |
| Filed 2018-02-26 Tx date 2017-09-25 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
45,000 | ||
| Filed 2018-01-30 Tx date 2018-01-30 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,600
-5,000 vol $0.52 each |
663,220 | |
| Filed 2018-01-29 Tx date 2018-01-29 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,600
-5,000 vol $0.52 each |
668,220 | |
| Filed 2017-09-28 Tx date 2017-09-25 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Hessing, Martin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
673,220 |